Product Code: GVR-4-68040-599-5
Clinical Trial Packaging Market Growth & Trends:
The global clinical trial packaging market size is anticipated to reach USD 5.46 billion by 2030, growing at a CAGR of 10.2% during the forecast period, according to a new report by Grand View Research, Inc. The clinical trial packaging industry is experiencing significant growth, driven by the rising number of clinical trials worldwide. With increasing R&D investments in pharmaceuticals and biologics, demand for specialized packaging solutions has surged. For example, the global clinical trial market is expanding due to advancements in oncology, rare diseases, and personalized medicine, requiring tailored packaging to maintain drug integrity. Additionally, regulatory agencies such as the FDA and EMA mandate stringent packaging standards, further boosting the need for compliant and secure packaging solutions.
The trend toward decentralized clinical trials (DCTs) is also reshaping packaging needs. With more trials conducted remotely, packaging must ensure drug stability during direct-to-patient shipments. For example, temperature-controlled shippers and patient-friendly kits with clear dosing instructions are becoming essential. Companies such as Catalent offer specialized solutions for DCTs, including just-in-time packaging to reduce waste and improve patient adherence. This shift is accelerating due to the COVID-19 pandemic, which highlighted the importance of flexible and resilient supply chains.
Sustainability concerns are influencing packaging strategies. Pharmaceutical companies are adopting eco-friendly materials, such as biodegradable blisters and recyclable secondary packaging, to meet environmental regulations and corporate sustainability goals. For instance, in April 2023, MAX Solutions introduced MAX Ecoblister, an innovative, eco-friendly alternative to traditional plastic blister packaging that combines a recyclable fiber top card with a compostable PaperFoam tray, offering brands a sustainable, turnkey solution that maintains high functionality and aesthetic appeal while eliminating plastic use.
Furthermore, the market for clinical trial packaging is dominated by North America, particularly the U.S., due to its robust pharmaceutical R&D ecosystem, high number of clinical trials, and stringent regulatory requirements from the FDA. Europe follows closely, driven by strong biopharmaceutical innovation in countries such as Germany, the UK, and Switzerland, along with EMA regulations emphasizing patient safety and packaging integrity. The Asia-Pacific (APAC) region is the fastest-growing market, fueled by increasing clinical trial outsourcing to countries such as India and China, cost advantages, and expanding healthcare infrastructure.
Clinical Trial Packaging Market Report Highlights:
- The plastic material segment accounted for the largest market share of over 53.0% in 2024.
- The metal material segment is expected to grow at the fastest CAGR of 11.1% during the forecast period.
- The vials & ampoules product segment accounted for the largest market share of over 31.0% in 2024 and is projected to grow at the fastest CAGR of 10.8% during the forecast period.
- Based on end use, the research laboratories segment dominated the clinical trial packaging industry in 2024 with the largest revenue share of over 51.0%.
- The clinical research organizations segment is expected to grow at the fastest CAGR of 10.8% over the forecast period of 2025 to 2030.
- North America dominated the regional market with the largest revenue share of over 37.0% in 2024.
- Asia Pacific is projected to grow at the fastest CAGR of 10.8% over the forecast period of 2025 to 2030.
- In February 2023, Gerresheimer AG introduced its new Clinical Trial Kit at Pharmapack in Paris, designed to accelerate drug development by providing a complete set of sterile Gx RTF vials in nest and tub or tray with matching closures, specifically tailored for early-phase development of new drugs, vaccines, and biologics.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Research Methodology
- 1.1.1. Market Segmentation
- 1.1.2. Market Definition
- 1.2. Research Scope & Assumptions
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
- 1.7. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot, 2024 (USD Million)
- 2.2. Segmental Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Global Clinical Trial Packaging Market Variables, Trends, and Scope
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Raw Material Trends
- 3.3.2. Manufacturing/Technology Trends
- 3.4. Sales Channel Analysis
- 3.5. Regulatory Framework
- 3.6. Market Dynamics
- 3.6.1. Market Driver Analysis
- 3.6.2. Market Restraint Analysis
- 3.6.3. Market Opportunity Analysis
- 3.6.4. Market Challenge Analysis
- 3.7. Business Environment Analysis
- 3.7.1. Porter's Five Forces Analysis
- 3.7.2. PESTEL Analysis
Chapter 4. Global Clinical Trial Packaging Market: Material Estimates & Trend Analysis
- 4.1. Key Takeaways
- 4.2. Material Movement Analysis & Market Share, 2024 & 2030
- 4.2.1. Glass
- 4.2.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.2.2. Plastic
- 4.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.2.3. Metal
- 4.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.2.4. Paper & Corrugated Fiber
- 4.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Global Clinical Trial Packaging Market: Product Estimates & Trend Analysis
- 5.1. Key Takeaways
- 5.2. Product Movement Analysis & Market Share, 2024 & 2030
- 5.2.1. Vials & Ampoules
- 5.2.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.2.2. Bottles
- 5.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.2.3. Bags & Pouches
- 5.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.2.4. Syringes
- 5.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.2.5. Others
- 5.2.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Global Clinical Trial Packaging Market: End Use Estimates & Trend Analysis
- 6.1. Key Takeaways
- 6.2. End Use Movement Analysis & Market Share, 2024 & 2030
- 6.2.1. Research Laboratories
- 6.2.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.2.2. Clinical Research Organizations
- 6.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.2.3. Drug Manufacturing Facilities
- 6.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Global Clinical Trial Packaging Market: Regional Estimates & Trend Analysis
- 7.1. Key Takeaways
- 7.2. Regional Movement Analysis & Market Share, 2024 & 2030
- 7.3. North America
- 7.3.1. North America Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. U.S. Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Canada Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Mexico Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.4. Europe
- 7.4.1. Europe Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Germany Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. UK
- 7.4.3.1. UK Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. France
- 7.4.4.1. France Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Italy Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Spain Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. China
- 7.5.2.1. China Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. India
- 7.5.3.1. India Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. Japan
- 7.5.4.1. Japan Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. South Korea Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Australia
- 7.5.6.1. Australia Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Brazil Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Argentina Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.7. Middle East & Africa
- 7.7.1. Middle East & Africa Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Saudi Arabia
- 7.7.2.1. Saudi Arabia Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. UAE
- 7.7.3.1. UAE Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.7.4. South Africa
- 7.7.4.1. South Africa Clinical Trial Packaging Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Global Clinical Trial Packaging Market: Competitive Landscape
- 8.1. Key Global Players & Recent Developments & Their Impact on the Industry
- 8.2. Vendor Landscape
- 8.2.1. List of Raw Material Suppliers & Channel Partners
- 8.2.2. Company Categorization
- 8.3. Company Market Position Analysis
- 8.4. Company Heat Map Analysis
- 8.5. Company Dashboard Analysis
- 8.6. Strategy Mapping
- 8.6.1. Expansions
- 8.6.2. Mergers & Acquisitions
- 8.6.3. Collaborations
- 8.6.4. New Product Launches
- 8.6.5. Others
Chapter 9. Company Listing (Overview, Financial Performance, Products Overview)
- 9.1. Thermo Fisher Scientific Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.2. Clinigen Limited
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.3. PCI Pharma Services
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.4. Yourway
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.5. WestRock Company
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.6. Oliver
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.7. CCL Industries Inc.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.8. Sharp Services, LLC
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.9. SCHOTT Pharma
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.10. Gerresheimer AG
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.11. Borosil Scientific
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.12. Nipro
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking